Can Mushrooms Help Reduce Prostate Cancer Risk?

The evidence is more specific than most people realize. Studies suggest that men who eat mushrooms regularly may face a meaningfully lower risk of developing prostate cancer, with L-ergothioneine, a potent antioxidant amino acid found in high concentrations in mushrooms, appearing to be a key driver. The findings are promising but not conclusive; no study has definitively proven that mushrooms prevent prostate cancer, and what follows explains exactly where the evidence stands.

What the Current Research Suggests

The most cited work in this space is a long-term prospective study published in the International Journal of Cancer, which followed roughly 36,000 Japanese men across 13 years. Men who ate mushrooms one to two times per week showed an approximately 8% lower risk of prostate cancer compared to men who rarely ate them. Those who ate mushrooms three or more times per week saw a 17% risk reduction, a pattern suggesting the relationship scales with frequency.

Global context matters here. Prostate cancer reached 1.32 million cases in 2021 and is projected to climb to 2.4 million cases annually by 2040, which is why diet-based prevention strategies are attracting serious research attention. Understanding prostate cancer risk factors is the starting point for anyone considering preventive steps. Diet is one of the few modifiable factors, and prostate cancer prevention increasingly points toward specific foods rather than general “eat healthy” advice.

That said, this is observational data. The men who ate more mushrooms may also have had other health-protective habits. Association isn’t causation, and the full picture of prostate cancer is considerably more complex. A 2024 paper in Clinical and Translational Medicine (Wang et al.) helps explain the biological plausibility behind these associations, and the full study text details the immune-mediated mechanisms.

Which Mushrooms Have Been Studied

Research has looked at both common culinary varieties and medicinal species. L-ergothioneine concentrations differ between species, and at least five distinct mushroom varieties carry notably higher levels than white button mushrooms. The US$7.3 billion medicinal mushrooms market in 2025 reflects just how much commercial interest these compounds have attracted. If you’re thinking about dietary changes for prostate health, reviewing foods for prostate health and cancer-fighting foods puts mushrooms in useful context alongside other well-studied options.

White Button Mushrooms

White button mushrooms (Agaricus bisporus), the variety most Americans eat, do show benefit in the research. Their L-ergothioneine levels fall below those of several medicinal species, but they’re by far the most-studied variety in clinical settings. Researchers at City of Hope National Cancer Center have been running clinical trials with white button mushroom extracts in men with prostate cancer, with results covered in the human evidence section below. According to the European Medical Journal, white button mushrooms halt cancer progression by activating immune defenses rather than acting directly on cancer cells.

Shiitake, Maitake, and Reishi Mushrooms

Three medicinal varieties carry significantly higher L-ergothioneine concentrations than white button mushrooms. Shiitake also contains lentinan, a beta-glucan polysaccharide with well-documented immunomodulatory properties. Maitake contains D-fraction beta-glucans that have been studied for immune support in cancer models. Reishi (Ganoderma lucidum) contains triterpenoids alongside beta-glucans, a distinct bioactive profile with its own research base. Work on beta-glucan particles from mushrooms and yeast confirms that the compound’s structural characteristics directly shape its biological activity.

How Mushrooms May Affect Prostate Health

Two main pathways appear in the literature: antioxidant activity and anti-inflammatory action. L-ergothioneine scavenges reactive oxygen species in prostate tissue and influences sirtuin signaling pathways (SIRT1, SIRT7), which regulate both oxidative stress responses and epigenetic cancer control. That dual mechanism is what makes it biologically interesting, most antioxidants do one or the other, not both.

Other dietary compounds with similar prostate-protective research behind them include quercetin, ellagic acid, and curcumin from turmeric. Mushrooms aren’t unique in this space, but the ergothioneine concentration they carry is distinctive.

Compounds That Show Promise

L-ergothioneine (EGT) is a naturally occurring amino acid your body can’t synthesize on its own, mushrooms are its primary dietary source. In prostate tissue, EGT is thought to reduce DNA oxidative damage and mitigate two specific inflammatory processes: chronic low-grade inflammation driven by reactive oxygen species, and the dysregulated immune-cell activity that can create a tumor-permissive microenvironment. A 2025 review in Biological Forum (Parvathy & Joseph) and a supporting ResearchGate analysis both confirm EGT’s role in sirtuin-regulated epigenetic control. Beta-glucans are the other major compound class; their potential as a natural frontier in prostate cancer treatment was explored in a 2025 International Journal of Medicinal Mushrooms review, and a detailed analysis of beta-glucan mechanisms covers inhibition of cell proliferation and induction of apoptosis in preclinical models. White button mushrooms also contain a conjugated linoleic acid isomer (CLA-9Z11E) that acts as an androgen receptor antagonist, relevant because prostate cancer growth is often androgen-driven.

What Animal and Lab Studies Reveal

Preclinical work shows that mushroom extracts inhibit prostate cancer cell growth in lab cultures and slow tumor development in mouse models. These findings are interesting, but they carry a real limitation: lab studies typically use concentrated extracts at doses far exceeding what you’d get from eating mushrooms. What white button mushroom extract does in tumor models may not translate directly to whole-food consumption. Animal results don’t automatically predict human outcomes. Researchers at ecancer describe how the supplement slows cancer progression through immune pathways, a mechanism distinct from direct cytotoxicity. That distinction matters for how you read the data.

The Strength of Human Evidence

The evidence hierarchy here runs from observational studies at the base, through small clinical trials, up to an ongoing randomized Phase II trial that hasn’t yet reported full results. No randomized controlled trial has established a causal link between mushroom consumption and reduced prostate cancer risk. That doesn’t mean the signal is weak, it means the most rigorous test is still in progress.

Research into supporting nutrients like zinc for prostate health follows a similar arc: strong mechanistic rationale, solid observational data, and clinical trials refining the picture.

Epidemiological Studies in Men

The 36,000-man cohort study is the anchor finding, but it’s observational. Participants who ate more mushrooms may have differed in diet quality, exercise habits, smoking status, or any number of other confounders. Global burden data from a 2021 prostate cancer analysis shows incidence patterns that correlate loosely with dietary habits, but population-level correlation isn’t proof of effect. These studies don’t prove cause-and-effect, and that distinction matters when making personal health decisions.

Clinical Trials on Mushroom Supplements

The most compelling human evidence comes from City of Hope’s Phase I and ongoing Phase II trials using white button mushroom tablets. The Phase I trial found a 36% PSA decline with no dose-limiting toxicities after three months of supplementation. The mechanism was immune-mediated: white button mushroom extracts reduced circulating myeloid-derived suppressor cells (MDSCs), reinvigorating T-cell and NK-cell activity against tumor tissue. MedicalXpress reporting and Healio’s clinical coverage both detail how MDSC suppression slows tumor progression. The Phase II trial (NCT04519879), listed on CenterWatch, is enrolling 132 men with recurrent prostate cancer. Results from supplement extracts in this context may not translate directly to whole culinary mushrooms eaten at typical serving sizes.

What We Still Don’t Know

Several important questions remain open. Optimal dosage and consumption frequency haven’t been established. It’s unknown how long you’d need to eat mushrooms regularly before any protective effect builds up. Bioavailability of L-ergothioneine from whole mushrooms versus concentrated extracts differs, but by how much isn’t known. Demographic variables, your age, family history, and ethnicity, likely modify any risk benefit, but the data isn’t detailed enough yet to say how. Treat these as active research questions, not settled answers.

Safety, Interactions, and Who Should Be Cautious

Culinary mushrooms eaten in normal food quantities are safe for most people. Medicinal mushroom supplements are a different matter. Natural doesn’t mean risk-free.

Known concerns include immunostimulatory effects: if you’re on immunosuppressants, after an organ transplant, for example, supplements that activate immune cells could interfere with your medication. Some mushroom supplements may amplify the effects of blood thinners like warfarin. People with autoimmune conditions should speak to a doctor before using medicinal mushroom products. Anyone undergoing active prostate cancer treatment, surgery, radiation, or hormone therapy, should tell their oncologist about any supplement use, since interactions with standard treatments haven’t been fully studied.

Other prostate-supportive supplements like saw palmetto and stinging nettle carry their own interaction profiles, which highlights why a thorough conversation with your doctor matters, particularly if you’re also managing benign prostatic hyperplasia (BPH) alongside cancer risk concerns. A 2025 global burden analysis in PMC notes that the men at highest risk for serious prostate cancer outcomes are often on multiple medications, making supplement-drug interactions a real clinical concern.

Practical Steps and When to Talk to Your Doctor

Mushrooms shouldn’t replace medical care or a well-balanced diet; they’re one component of a broader approach to prostate health. Don’t assume a serving of shiitake stir-fry delivers the same biological dose used in a clinical trial.

Practically speaking, adding mushrooms to your regular diet is low-risk and worthwhile. They fit naturally into an enlarged prostate diet built around vegetables, fish, and anti-inflammatory foods. Pairing them with other researched options, green tea and lycopene-rich foods, builds a diet with multiple studied mechanisms working in concert.

See a doctor before starting any mushroom supplement if you: are currently being treated for prostate cancer, take immunosuppressants or anticoagulants, have an autoimmune condition, or are preparing for surgery. And if you’re experiencing urinary changes, pelvic discomfort, or blood in urine, see a doctor before adjusting your diet at all; those symptoms need evaluation first.

Frequently Asked Questions

Can you take mushroom supplements alongside prostate medications?

Check with your doctor first. Some mushroom supplements may interact with blood thinners, immunosuppressants, or hormone therapies used in prostate cancer treatment. Disclosing all supplements to your prescribing physician is standard good practice.

How much mushroom do you need to eat or take to potentially see a benefit?

The observational data associated one to two servings per week with an 8% risk reduction and three or more servings per week with a 17% reduction. Supplement dosing hasn’t been standardized in clinical trials yet, so no specific daily amount can be recommended at this point.

Are fresh mushrooms as effective as supplements, or do you need to take a pill?

The clinical trials showing PSA reduction and immune effects used concentrated tablet extracts, which deliver a controlled dose of bioactive compounds. Whole culinary mushrooms contain the same compounds but at lower, more variable concentrations. Both may support prostate health, but they likely operate at different potencies, and the research base is considerably stronger for extracts.

Conclusion

What the Current Research Suggests

The question of whether mushrooms can help reduce prostate cancer risk has a genuinely encouraging but still-evolving answer. Observational studies show consistent associations, L-ergothioneine and beta-glucans provide a credible biological rationale, and City of Hope’s clinical trials point to real immune-mediated effects on PSA and tumor progression. But no RCT has yet proven that eating mushrooms prevents prostate cancer. The honest takeaway: adding mushrooms to a prostate-healthy diet makes sense, pursuing medicinal mushroom supplements warrants a conversation with your doctor, and this remains an active area of research worth watching.